Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on September 3, 2025
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 3, 2025
PETACH TIKVA, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that senior management will participate in the upcoming …
Thrive Launches Managed AI Services to Help Businesses Succeed with AI
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Thrive, a global technology outsourcing provider for cybersecurity, cloud, and IT managed services, today announced its Managed AI services, a new offering that provides mid-market businesses with a dedicated team …
Aterian Announces U.S. Launch of Squatty Potty Flushable Wipes
GlobeNewswire
·
September 3, 2025
Newest Bathroom Essential from the Creators of the #1 Way to #2 100% Plant-Based Fibers, Hypoallergenic, and Septic Safe SUMMIT, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the launch …
Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
GlobeNewswire
·
September 3, 2025
Live moderated webcast on Thursday, September 4th at 4:00 PM ET Access the event here BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload …
Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025
GlobeNewswire
·
September 3, 2025
THE WOODLANDS, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced data from a study of patients describing the physical and psychological impact of diabetic peripheral neuropathic pain (DPNP), despite …
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
GlobeNewswire
·
September 3, 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today announced that, following its strategic review of the cryptocurrency and stablecoin market, engagement with third- …
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
GlobeNewswire
·
September 3, 2025
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA acceptance starts the review process and sets timing for potentially the first new FDA-approved …
Coherus Oncology to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 3, 2025
REDWOOD CITY, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS) today announced that the company will be webcasting its participation in the following upcoming conferences: Baird 2025 Global Healthcare Conference in New York, …
IQSTEL and Cycurion Execute $1 Million Stock Exchange, Announce Dividend Distribution and Strategic AI Cybersecurity Alliance
GlobeNewswire
·
September 3, 2025
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- IQSTEL Inc. (NASDAQ: IQST) (“IQSTEL”) and Cycurion Inc. (NASDAQ: CYCU) (“Cycurion”) today announced the execution of their previously announced $1 million stock exchange, finalizing the mutual equity agreement …
SaverOne Signs Agreement with Fandango to Deploy its Driver Distraction Prevention Solution Across Heavy Truck Fleet
GlobeNewswire
·
September 3, 2025
Expands Presence in Heavy-Truck Sector, Reinforcing Strategic Penetration into High-Risk Commercial Fleets Petah Tikvah, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in …
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
GlobeNewswire
·
September 3, 2025
SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent …
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
GlobeNewswire
·
September 3, 2025
10-minute home test detects early kidney damage in diabetic and hypertensive patients Hypertension affects roughly one-third of adults in the UAE Diabetes impacts approximately one in four UAE nationals IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- …
ToolKitX’s permit to work (ePTW) system for safer work, and faster approvals
GlobeNewswire
·
September 3, 2025
MAINZ, GERMANY – September 03, 2025 - ToolKitX’s permit to work (ePTW) system is designed for high-risk operations that require tight safety protocols and fast, trackable approvals. Over the last 8 years, we have processed over 200,000 permits for …
NUMERATOR LAUNCHT VERIFIED VOICES IN DEUTSCHLAND
GlobeNewswire
·
September 3, 2025
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Numerator, ein globales Daten- und Technologieunternehmen, hat heute den Start seiner Self-Service-Marktforschungsplattform Verified Voices in Deutschland bekannt gegeben. Verified Voices nutzt durch Kassenbons …
Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025
GlobeNewswire
·
September 3, 2025
LAKE FOREST, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during …
Delinea Report Reveals Only 44% of Organizations Are Fully Equipped to Support Secure AI
GlobeNewswire
·
September 3, 2025
SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, today published new research on the impact of artificial intelligence in reshaping …
Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research
GlobeNewswire
·
September 3, 2025
FLORHAM PARK, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the acceptance …
NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
GlobeNewswire
·
September 3, 2025
WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an interventional …
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, announced today the …
Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program
GlobeNewswire
·
September 3, 2025
September 16 event to highlight preclinical data on the combination of FTI agents with multiple classes of targeted therapies October 18 event to review clinical data from the ESMO Congress 2025, including first clinical data from KO-2806 SAN DIEGO, Sept. …